Ondansetron HCL

VOMIVIB

COMPOSITION
Ondansetron HCL2MG
SPECIFICATION
FORMPEDIATRIC
PACKING 30ML
PACKING TYPE
MRP34

DESCRIPTION

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [PubChem]

SIDE EFFECTS

Low blood pressure and fainting, sudden blindness, severe constipation

INDICATION

For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, postoperation, and radiation. Also used for the treatment of postoperative nausea and vomiting.